Konkurencja i konsument · 19/12/1994

Roche Holding Ltd., et al.; Prohibited Trade Practices, and Affirmative Cooperative Actions

In settlement of alleged violations of federal law prohibiting unfair acts and practices and unfair methods of competition, this consent order, among other things, requires Roche to divest Syva's drugs of abuse testing (DAT) business within 12 months to a Commission- approved buyer, to operate the Syva assets separately from its own DAT business pending the divestiture, and to obtain, for ten years, prior Commission approval before acquiring assets or interests of any entity involved in the market for drugs of abuse reagent products.